Tourmaline Bio Stock Market Value
| TRML Stock | 26.04 0.38 1.48% |
| Symbol | Tourmaline |
Tourmaline Bio Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tourmaline Bio. If investors know Tourmaline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tourmaline Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.49) | Return On Assets (0.24) | Return On Equity (0.32) |
The market value of Tourmaline Bio is measured differently than its book value, which is the value of Tourmaline that is recorded on the company's balance sheet. Investors also form their own opinion of Tourmaline Bio's value that differs from its market value or its book value, called intrinsic value, which is Tourmaline Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tourmaline Bio's market value can be influenced by many factors that don't directly affect Tourmaline Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tourmaline Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tourmaline Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tourmaline Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Tourmaline Bio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Tourmaline Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Tourmaline Bio.
| 06/04/2024 |
| 12/01/2024 |
If you would invest 0.00 in Tourmaline Bio on June 4, 2024 and sell it all today you would earn a total of 0.00 from holding Tourmaline Bio or generate 0.0% return on investment in Tourmaline Bio over 180 days. Tourmaline Bio is related to or competes with Tff Pharmaceuticals, Eliem Therapeutics, Inhibrx, and Enliven Therapeutics. Tourmaline Bio is entity of United States More
Tourmaline Bio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Tourmaline Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Tourmaline Bio upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.72 | |||
| Information Ratio | 0.1314 | |||
| Maximum Drawdown | 23.01 | |||
| Value At Risk | (5.33) | |||
| Potential Upside | 7.96 |
Tourmaline Bio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tourmaline Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Tourmaline Bio's standard deviation. In reality, there are many statistical measures that can use Tourmaline Bio historical prices to predict the future Tourmaline Bio's volatility.| Risk Adjusted Performance | 0.1342 | |||
| Jensen Alpha | 0.4708 | |||
| Total Risk Alpha | (0.02) | |||
| Sortino Ratio | 0.1451 | |||
| Treynor Ratio | 0.4343 |
Tourmaline Bio Backtested Returns
Tourmaline Bio appears to be not too volatile, given 3 months investment horizon. Tourmaline Bio owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.2, which indicates the firm had a 0.2% return per unit of risk over the last 3 months. By inspecting Tourmaline Bio's technical indicators, you can evaluate if the expected return of 0.84% is justified by implied risk. Please review Tourmaline Bio's Risk Adjusted Performance of 0.1342, coefficient of variation of 606.5, and Semi Deviation of 3.19 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Tourmaline Bio holds a performance score of 16. The entity has a beta of 1.54, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Tourmaline Bio will likely underperform. Please check Tourmaline Bio's downside variance, as well as the relationship between the accumulation distribution and market facilitation index , to make a quick decision on whether Tourmaline Bio's existing price patterns will revert.
Auto-correlation | -0.02 |
Very weak reverse predictability
Tourmaline Bio has very weak reverse predictability. Overlapping area represents the amount of predictability between Tourmaline Bio time series from 4th of June 2024 to 2nd of September 2024 and 2nd of September 2024 to 1st of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Tourmaline Bio price movement. The serial correlation of -0.02 indicates that only 2.0% of current Tourmaline Bio price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.02 | |
| Spearman Rank Test | 0.14 | |
| Residual Average | 0.0 | |
| Price Variance | 13.33 |
Tourmaline Bio lagged returns against current returns
Autocorrelation, which is Tourmaline Bio stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Tourmaline Bio's stock expected returns. We can calculate the autocorrelation of Tourmaline Bio returns to help us make a trade decision. For example, suppose you find that Tourmaline Bio has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Tourmaline Bio regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Tourmaline Bio stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Tourmaline Bio stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Tourmaline Bio stock over time.
Current vs Lagged Prices |
| Timeline |
Tourmaline Bio Lagged Returns
When evaluating Tourmaline Bio's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Tourmaline Bio stock have on its future price. Tourmaline Bio autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Tourmaline Bio autocorrelation shows the relationship between Tourmaline Bio stock current value and its past values and can show if there is a momentum factor associated with investing in Tourmaline Bio.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Tourmaline Bio Correlation, Tourmaline Bio Volatility and Tourmaline Bio Alpha and Beta module to complement your research on Tourmaline Bio. For more information on how to buy Tourmaline Stock please use our How to buy in Tourmaline Stock guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Tourmaline Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.